PortfoliosLab logoPortfoliosLab logo
LLY vs. AAPL
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

LLY vs. AAPL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eli Lilly and Company (LLY) and Apple Inc (AAPL). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

LLY vs. AAPL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LLY
Eli Lilly and Company
-14.27%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%
AAPL
Apple Inc
-6.56%9.05%30.71%49.01%-26.40%34.65%82.31%88.96%-5.39%48.46%

Fundamentals

Market Cap

LLY:

$825.96B

AAPL:

$3.76T

EPS

LLY:

$22.96

AAPL:

$7.89

PE Ratio

LLY:

40.06

AAPL:

32.15

PEG Ratio

LLY:

0.81

AAPL:

4.23

PS Ratio

LLY:

12.68

AAPL:

8.69

PB Ratio

LLY:

31.13

AAPL:

42.62

Total Revenue (TTM)

LLY:

$65.18B

AAPL:

$435.62B

Gross Profit (TTM)

LLY:

$54.62B

AAPL:

$206.16B

EBITDA (TTM)

LLY:

$27.94B

AAPL:

$150.07B

Returns By Period

In the year-to-date period, LLY achieves a -14.27% return, which is significantly lower than AAPL's -6.56% return. Over the past 10 years, LLY has outperformed AAPL with an annualized return of 30.92%, while AAPL has yielded a comparatively lower 26.13% annualized return.


LLY

1D
3.74%
1M
-12.57%
YTD
-14.27%
6M
20.93%
1Y
12.19%
3Y*
39.90%
5Y*
39.16%
10Y*
30.92%

AAPL

1D
2.90%
1M
-3.93%
YTD
-6.56%
6M
-0.14%
1Y
14.75%
3Y*
16.01%
5Y*
16.20%
10Y*
26.13%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LLY vs. AAPL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY
LLY Risk / Return Rank: 5151
Overall Rank
LLY Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 4848
Sortino Ratio Rank
LLY Omega Ratio Rank: 4949
Omega Ratio Rank
LLY Calmar Ratio Rank: 5353
Calmar Ratio Rank
LLY Martin Ratio Rank: 5454
Martin Ratio Rank

AAPL
AAPL Risk / Return Rank: 5959
Overall Rank
AAPL Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
AAPL Sortino Ratio Rank: 5454
Sortino Ratio Rank
AAPL Omega Ratio Rank: 5656
Omega Ratio Rank
AAPL Calmar Ratio Rank: 5959
Calmar Ratio Rank
AAPL Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LLY vs. AAPL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and Apple Inc (AAPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LLYAAPLDifference

Sharpe ratio

Return per unit of total volatility

0.29

0.47

-0.18

Sortino ratio

Return per unit of downside risk

0.69

0.92

-0.23

Omega ratio

Gain probability vs. loss probability

1.10

1.13

-0.04

Calmar ratio

Return relative to maximum drawdown

0.42

0.74

-0.32

Martin ratio

Return relative to average drawdown

1.02

2.30

-1.28

LLY vs. AAPL - Sharpe Ratio Comparison

The current LLY Sharpe Ratio is 0.29, which is lower than the AAPL Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of LLY and AAPL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


LLYAAPLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.29

0.47

-0.18

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.23

0.59

+0.63

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.04

0.91

+0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.56

0.43

+0.13

Correlation

The correlation between LLY and AAPL is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

LLY vs. AAPL - Dividend Comparison

LLY's dividend yield for the trailing twelve months is around 0.68%, more than AAPL's 0.41% yield.


TTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.68%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
AAPL
Apple Inc
0.41%0.38%0.40%0.49%0.70%0.49%0.61%1.04%1.79%1.45%1.93%1.93%

Drawdowns

LLY vs. AAPL - Drawdown Comparison

The maximum LLY drawdown since its inception was -68.24%, smaller than the maximum AAPL drawdown of -81.80%. Use the drawdown chart below to compare losses from any high point for LLY and AAPL.


Loading graphics...

Drawdown Indicators


LLYAAPLDifference

Max Drawdown

Largest peak-to-trough decline

-68.24%

-81.80%

+13.56%

Max Drawdown (1Y)

Largest decline over 1 year

-30.26%

-22.99%

-7.27%

Max Drawdown (5Y)

Largest decline over 5 years

-34.48%

-33.36%

-1.12%

Max Drawdown (10Y)

Largest decline over 10 years

-34.48%

-38.52%

+4.04%

Current Drawdown

Current decline from peak

-17.00%

-11.24%

-5.76%

Average Drawdown

Average peak-to-trough decline

-19.25%

-29.71%

+10.46%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.39%

7.38%

+5.01%

Volatility

LLY vs. AAPL - Volatility Comparison

Eli Lilly and Company (LLY) has a higher volatility of 9.04% compared to Apple Inc (AAPL) at 5.58%. This indicates that LLY's price experiences larger fluctuations and is considered to be riskier than AAPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


LLYAAPLDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.04%

5.58%

+3.46%

Volatility (6M)

Calculated over the trailing 6-month period

26.21%

15.09%

+11.12%

Volatility (1Y)

Calculated over the trailing 1-year period

42.44%

31.66%

+10.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.14%

27.46%

+4.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.80%

28.94%

+0.86%

Financials

LLY vs. AAPL - Financials Comparison

This section allows you to compare key financial metrics between Eli Lilly and Company and Apple Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
19.29B
143.76B
(LLY) Total Revenue
(AAPL) Total Revenue
Values in USD except per share items

LLY vs. AAPL - Profitability Comparison

The chart below illustrates the profitability comparison between Eli Lilly and Company and Apple Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
85.1%
48.2%
Portfolio components
LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a gross profit of 16.41B and revenue of 19.29B. Therefore, the gross margin over that period was 85.1%.

AAPL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Apple Inc reported a gross profit of 69.23B and revenue of 143.76B. Therefore, the gross margin over that period was 48.2%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported an operating income of 8.78B and revenue of 19.29B, resulting in an operating margin of 45.5%.

AAPL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Apple Inc reported an operating income of 50.85B and revenue of 143.76B, resulting in an operating margin of 35.4%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a net income of 6.64B and revenue of 19.29B, resulting in a net margin of 34.4%.

AAPL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Apple Inc reported a net income of 42.10B and revenue of 143.76B, resulting in a net margin of 29.3%.